IP vs PRLD
International Paper (IP) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the IP and PRLD stock pages for the full models.
Not investment advice.